Press Release

Merck & Co. Inc. Posted on:30 Jul 10 Merck & Co., Inc. (NYSE: MRK) today announced financial results for the second quarter of 2010. The company reported non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the second quarter of $0.86, which excludes purchase accounting adjustments, merger-related expenses, restructuring costs and the gain on AstraZeneca's asset ...

Merck Announces Second-Quarter 2010 Financial Results

WHITEHOUSE STATION, N.J.----Merck & Co., Inc. today announced financial results for the second quarter of 2010. The company reported non-GAAP earnings per share for the second quarter of $0.86, which excludes purchase accounting adjustments, merger-related expenses, restructuring costs and the gain on AstraZeneca's asset option exercise.

Headache basics: Tension, migraine, cluster

Headaches are one of the most common illnesses, accounting for more than 18 million visits to the doctor every year. Headaches are not all the same and therefore shouldn't be treated as such. The three types of headaches people suffer from most are tension headaches, migraines and cluster headaches.

Arena Sees Continued Strong Growth in Second Quarter With 24% Increase in Subscription Sales

FOSTER CITY, CA--(Marketwire - 07/29/10) - Arena Solutions , a provider of on-demand software that helps small and mid-size manufacturers manage their complex and constantly changing product record, today announced that the company saw subscription sales continue to grow in the second quarter ending June 30, 2010, with an increase of 24% over the same period one year earlier. Sales were strong ...

Safeguard Scientifics Announces Second Quarter 2010 Financial Results

WAYNE, Pa.----Safeguard Scientifics, Inc. , a holding company that builds value in growth-stage life sciences and technology companies, today announced that aggregate revenue of its partner companies for the three months ended June 30, 2010 was $91.6 million, up 47% from $62.3 million for the same partner companies in the same period of 2009.

NMT Medical Announces Second-Quarter 2010 Financial Results

BOSTON----NMT Medical, Inc. , an advanced medical technology company that designs, develops, manufactures and markets proprietary implant technologies that allow interventional cardiologists to treat structural heart disease through minimally invasive, catheter-based procedures, today announced financial results for the quarter ended June 30, 2010.